Literature DB >> 16198775

Epidemiology of psoriatic arthritis in the population of the United States.

Joel M Gelfand1, Dafna D Gladman, Philip J Mease, Nana Smith, David J Margolis, Tamar Nijsten, Robert S Stern, Steven R Feldman, Tara Rolstad.   

Abstract

BACKGROUND: Estimates of the prevalence of psoriatic arthritis vary widely and are usually not determined by population-based studies.
OBJECTIVES: We sought to determine the prevalence of psoriatic arthritis and the impact of the disease on quality of life in the US population.
METHODS: Patients were selected randomly from the US population and were interviewed by telephone. Cases were defined as patients who reported a physician diagnosis of psoriasis and psoriatic arthritis.
RESULTS: Interviews of 27,220 persons were conducted; 601 of the interviewees had psoriasis and 71 had psoriasis and psoriatic arthritis. The prevalence of psoriatic arthritis was 0.25% (95% confidence interval [CI]: 0.18%, 0.31%). The prevalence of psoriatic arthritis among patients with psoriasis was 11% (95% CI: 9%, 14%) and varied substantially based on self-reporting of the extent of skin involvement with psoriasis. Thirty-nine percent of patients with psoriatic arthritis indicated that it was a large problem in everyday life. LIMITATIONS: Psoriatic arthritis was classified on the basis of the patient's self-report.
CONCLUSION: Psoriatic arthritis affects an estimated 520,000 patients in the US population, and many rate it as a large problem in everyday life. The prevalence varies widely based on the extent of skin involvement, which demonstrates the importance of performing broadly representative studies to measure the prevalence of psoriatic arthritis.

Entities:  

Mesh:

Year:  2005        PMID: 16198775     DOI: 10.1016/j.jaad.2005.03.046

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  135 in total

Review 1.  The genetics of psoriasis and psoriatic arthritis.

Authors:  Vinod Chandran
Journal:  Clin Rev Allergy Immunol       Date:  2013-04       Impact factor: 8.667

Review 2.  Assessing long-term drug safety: lessons (re) learned from raptiva.

Authors:  Nicole M Seminara; Joel M Gelfand
Journal:  Semin Cutan Med Surg       Date:  2010-03

3.  The burden of psoriatic arthritis: a literature review from a global health systems perspective.

Authors:  Seina Lee; Alan Mendelsohn; Evelyn Sarnes
Journal:  P T       Date:  2010-12

4.  Identification of risk factors for psoriatic arthritis: scientific opportunity meets clinical need.

Authors:  Alexis Ogdie; Joel M Gelfand
Journal:  Arch Dermatol       Date:  2010-07

Review 5.  The Epidemiology of Psoriatic Arthritis.

Authors:  Alexis Ogdie; Pamela Weiss
Journal:  Rheum Dis Clin North Am       Date:  2015-09-11       Impact factor: 2.670

Review 6.  Disease burden and treatment challenges of psoriatic arthritis in Africa and the Middle East.

Authors:  Mohamed Bedaiwi; Ibrahim A Al-Homood; Ayman El-Garf; Imad Uthman; Nancy Sunna; Reenad Nassier; Haytham Mohamed; Jamal Al Saleh
Journal:  Rheumatol Int       Date:  2019-05-27       Impact factor: 2.631

7.  Alcohol intake and risk of incident psoriatic arthritis in women.

Authors:  Shaowei Wu; Eunyoung Cho; Wen-Qing Li; Jiali Han; Abrar A Qureshi
Journal:  J Rheumatol       Date:  2015-04-01       Impact factor: 4.666

8.  Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study.

Authors:  Floranne C Wilson; Murat Icen; Cynthia S Crowson; Marian T McEvoy; Sherine E Gabriel; Hilal Maradit Kremers
Journal:  Arthritis Rheum       Date:  2009-02-15

Review 9.  Managing moderate-to-severe psoriasis in the elderly.

Authors:  Nicola Balato; Cataldo Patruno; Maddalena Napolitano; Angela Patrì; Fabio Ayala; Raffaele Scarpa
Journal:  Drugs Aging       Date:  2014-04       Impact factor: 3.923

10.  Reliability, validity and responsiveness to change of the Patient Report of Extent of Psoriasis Involvement (PREPI) for measuring body surface area affected by psoriasis.

Authors:  E D Dommasch; D B Shin; A B Troxel; D J Margolis; J M Gelfand
Journal:  Br J Dermatol       Date:  2009-11-10       Impact factor: 9.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.